Pathology

Article	Citations
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation	126
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings	73
The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment	54
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent	46
Clear cell papillary renal cell carcinoma: an update after 15 years	37
NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm	34
Chromophobe renal cell carcinoma: current and controversial issues	33
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays	33
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour	29
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings	28
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection	27
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis	25
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays	25
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2	25
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma	23
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship	23
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour	23
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia	21
Granular necrosis: a distinctive form of cell death in malignant tumours	21
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes	20
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes	20
Staging of renal cell carcinoma: current progress and potential advances	20
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer	19
HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma	17
Emergence of Japanese encephalitis in Australia: a diagnostic perspective	17

Malignant mesothelioma in situ: diagnostic and clinical considerations	17
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients	16
Molecular pathology of prostate cancer: a practical approach	16
New developments in non-Hodgkin lymphoid malignancies	16
Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge	15
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2	14
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study	14
Machine learning and augmented human intelligence use in histomorphology for haematolymphoid disorders	13
Myeloid somatic mutation panel testing in myeloproliferative neoplasms	13
Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein–Barr virus infection and survival	13
Prognostic features of Annexin A2 expression in prostate cancer	13
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context	13
Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use	13
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer	12
EBV positive fibrin/chronic inflammation associated diffuse large B-cell lymphoma: an incidental finding associated with a breast implant	12
Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer	12
Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens	12
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection	12
Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases	12
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations	12
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low	12
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant	12
Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia	11
Tumour-like lesions of the urinary bladder	11
Stage T1 bladder cancer: diagnostic criteria and pitfalls	11
Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortality	11
Role of cell-free DNA in haematological malignancies	11
Clonal haematopoiesis of emerging significance	10
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics	10
Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas!	10
Detection and identification of dermatophyte fungi in clinical samples using a commercial multiplex tandem PCR assay	10
Two cases of ZC3H7B-BCOR high grade endometrial stromal sarcoma with an extension on its morphological features	10
The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma	10
An evaluation of existing manual blood film schistocyte quantitation guidelines and a new proposed method	10
Variability in D-dimer reporting revisited	10
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory	10
Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer	10
Benign mimics of prostate cancer	9
Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status	9
An update on genomic aberrations in Spitz naevi and tumours	9
The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes	9
CAR-T cell therapy: practical guide to routine laboratory monitoring	9
Atypia in breast pathology: what pathologists need to know	9
Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies	9
Genomic analysis of Lactococcus garvieae isolates	9
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients	9
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests	9
Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding	9
GLI activated epithelioid cell tumour: report of a case and proposed new terminology	9
Progression of mesothelioma in situ to invasive disease 4 years and 10 months after initial diagnosis	8

NKX3.1 expression in cervical ‘adenoid basal cell carcinoma’: another gynaecological lesion with prostatic differentiation?	8
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020	8
Comparison of a commercial real-time PCR panel to routine laboratory methods for the diagnosis of meningitis-encephalitis	8
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures	8
Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology s	8
Should the solid variant of odontogenic keratocyst and keratoameloblastoma be classified as the same entity? A clinicopathological analysis of nine cases and a review of the literature	8
Genomic characterisation of diffuse large B-cell lymphoma	8
Oral anticoagulation therapy: an update on usage, costs and associated risks	8
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection	8
A Mycobacterium species for Crohn's disease?	8
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis	8
Urothelial carcinoma in situ: diagnostic update	8
Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma	8
Hybrid sclerosing epithelioid fibrosarcoma/low grade fibromyxoid sarcoma arising in the small intestine with distinct HEY1-NCOA2 gene fusion	8
The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma	8
SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability	8
Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy	7
Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection?	7
Prostatic stromal proliferations: a review	7
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney	7
Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma	7
Tumour mutational burden: an overview for pathologists	7
Diagnostic error, uncertainty, and overdiagnosis in melanoma	7
Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex	7
Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma	7
Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site	7
Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients	7
Erythrocyte interaction with neutrophil extracellular traps in coronary artery thrombosis following myocardial infarction	7
Programmed death ligand 1 protein expression, histological tumour differentiation and intratumoural heterogeneity in pulmonary adenocarcinoma	7
LncRNA PVT1 promotes the malignant progression of acute myeloid leukaemia via sponging miR-29 family to increase WAVE1 expression	7
Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas	7
The biology of pancreatic cancer morphology	6
The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders	6
Assessment of analytical bias in ferritin assays and impact on functional reference limits	6
Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia	6
Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition	6
Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome	6
Brentuximab-related apoptotic colopathy	6
Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas	6
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer	6
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing	6
Gleason grade 5 prostate cancer: sub-patterns and prognosis	6
Quantitative Pneumocystis jirovecii real-time PCR to differentiate disease from colonisation	6
A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care	6
Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method	6
Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting	6
Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene	6
HPV-driven anal neoplasia: review and recent developments	6
Metastatic melanoma and rare melanoma variants: a review	6
Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system	6
Cytological diagnosis of mesothelioma in situ versus invasive mesothelioma	6
Reference intervals of spot urine copper excretion in preschool children and potential application in pre-symptomatic screening of Wilson disease	6
Knowledge at what cost? An audit of the utility of panfungal PCR performed on bronchoalveolar lavage fluid specimens at a tertiary mycology laboratory	6
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial	6
Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms	5
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting	5
Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study	5
Using deep learning for quantification of cellularity and cell lineages in bone marrow biopsies and comparison to normal age-related variation	5
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1	5
Inflammatory pseudotumour arising secondary to VEXAS syndrome	5
Blood culture quality assurance: what Australasian laboratories are measuring and opportunities for improvement	5
Impact of new myeloma agents on the transfusion laboratory	5
Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma	5
Comparison of three commercially available ELISA assays for anti-infliximab antibodies	5
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis	5
Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia	5
Proficiency testing for SARS-CoV-2 whole genome sequencing	5
Actinomycosis canaliculitis	5
Reactive angioendotheliomatosis presenting as livedo racemosa secondary to propylthiouracil	5
A NUT carcinoma lacking squamous differentiation and expressing TTF1	5
The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma	5
Inflammatory pseudotumour-like follicular dendritic cell tumour of the colon with plasmacytosis mimicking EBV-positive lymphoproliferative disorder	5
Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples	5
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features	5
An overview of artificial intelligence/deep learning	5
Publication metrics: what do they mean?	5
Controversies in appendiceal pathology: mucinous and goblet cell neoplasms	4
NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China	4
Recurrent plexiform angiomyxoid myofibroblastic tumour (PAMT) of the stomach with aggressive behaviour	4
Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma	4

Imaging flow cytometry shows monosomy 17 in circulating plasma cells in myeloma	4
Gastrointestinal polyposis with associated cutaneous manifestations	4
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting	4
An update on genetic aberrations in T-cell neoplasms	4
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases	4
The fluorescence enzyme immunoassay has greater utility than the gel precipitin test for the detection of specific IgG antibodies to Aspergillus fumigatus in the diagnosis of allergic bronchopulmonary	4
Candida duobushaemulonii sepsis and Candida auris co-isolation following hospitalisation in Vietnam	4
Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study	4
Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis	4
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population	4
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of mult	4
Highlights of infectious agents in tissue	4
Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)	4
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma	4
Gonadoblastoma in individuals with a normal karyotype and no evidence of a disorder of sex development	4
Agminated Spitz naevus with an activating HRAS Q61R mutation	4
Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories	4
Epstein–Barr virus is a promoter of lymphoma cell metastasis	4
Report of a classic primordial odontogenic tumour and an unusual mixed odontogenic tumour with features of primordial odontogenic tumour: diagnostic implications	4
Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours	4
Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA	4
Expression and localisation of methylthioadenosine phosphorylase (MTAP) in oral squamous cell carcinoma and their significance in epithelial-to-mesenchymal transition	4
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma	4
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax	4
Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation	4
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort	4
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer	4
Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case	4
Usual interstitial pneumonia: a review of the pathogenesis and discussion of elastin fibres, type II pneumocytes and proposed roles in the pathogenesis	4
Spinal calcifying pseudoneoplasm of the neuraxis (CAPNON) and CAPNON-like lesions: CAPNON overlapping with calcified synovial cysts	4
Cemento-osseous dysplasia is caused by RAS-MAPK activation	4
Assessment of European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines in an Australian paediatric population	4
Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay	4
SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis	3
The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature	3
Idiopathic granulomatous mastitis and cystic neutrophilic granulomatous mastitis: two sides of the same coin or distinct entities?	3
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy	3
Review of full blood count reference interval using a large cohort of first-time plasmapheresis blood donors	3
Biology and genetics of acquired and congenital melanocytic naevi	3
YJ5 as an immunohistochemical marker of osteogenic lineage	3
Whole genome sequencing of Salmonella enterica serovar Saintpaul for elucidating the mechanisms of resistance to third generation cephalosporins	3
Meningioma sampling: how much is enough for the accurate grading of atypical meningiomas?	3
Missing parameters in malignant polyp histology reports: can appropriate decisions be made?	3
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia	3
In-house multiplex ligation-dependent probe amplification assay for citrin deficiency: analytical validation and novel exonic deletions in SLC25A13	3
Efficacy of training a deep learning model for mitotic count in breast carcinoma using opensource software	3
Liver mesenchymal neoplasms: something old, something new	3
Design, development and deployment of a web-based patient registry for rare genetic lipid disorders	3
Intratubular large cell hyalinising Sertoli-cell neoplasia: a rare entity associated with Peutz–Jeghers syndrome	3
Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases	3
Panfungal PCR on formalin-fixed, paraffin-embedded tissue: to proceed or not proceed?	3
Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems	3
Improved performance of confirmatory assays for detecting dense fine speckled (DFS) 70 antibodies	3
Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram	3
Beware the inflammatory cell-rich colonic polyp: a rare case of EBV-positive inflammatory pseudotumour-like follicular dendritic cell sarcoma with increased IgG4-positive plasma cells	3
Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C	3
Assessing the performance of the Cepheid Xpert in identifying and differentiating methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus from blood culture bottl	3
Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications	3
Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer	3
Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants	3
The choice of anti-LEDGF/DFS70 assay matters: a comparative study of six assays	3
Melanocytic naevi, melanocytomas and emerging concepts	3
IgG4-related pseudotumours: a series of 12 cases and a review of the literature	3
Intravascular epithelioid haemangioma of deep soft tissue with novel SETD1B-FOSB gene rearrangement	3
Prevalence of the EGFR T790M and other resistance mutations in the Australian population and histopathological correlation in a small subset of cases	3
A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma	3
Blue naevi and the blue tumour spectrum	3
The future of laboratory testing in chronic lymphocytic leukaemia	3
Intracranial mesenchymal tumour with EWSR1 gene rearrangement: the first report of intracranial mesenchymal tumour with FET-CREB fusion from India	3
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread	3
Gynaecological or gastrointestinal origin? Recognising Müllerian neoplasms with gastrointestinal phenotype and determining the primary site in selected entities	3
Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease	3
Mesenchymal tumours with melanocytic expression: a potential pitfall in the differential diagnosis of malignant melanoma	3
Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis	3
Malignant gastrointestinal neuroectodermal tumour in soft tissue	3
Incidental intravascular large B-cell lymphoma in a renal cell carcinoma	3
Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis	3
Contributions of genetics to the evolution of the diagnostic classification of renal cell neoplasia: a personal perspective	3
Prolonged PCR positivity in elderly patients infected with SARS-CoV-2	3
Analysis of SARS-CoV-2 real-time PCR test CT values across a population may afford useful information to assist public health efforts and add refinement to epidemiological models	3
Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma	3
Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing	3
Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis	3
ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?	3
Relative effects of direct spread, lymph node metastasis and venous invasion in relation to blood borne distant metastasis present at the time of resection of colorectal cancer	3
NTRK fusions in solid tumours: what every pathologist needs to know	3
Gluten-free diet adherence and implications for the diagnosis of coeliac disease	3
An unusual case of invasive lobular carcinoma with abundant extracellular mucin	2
Cotton wool balls are an effective urine collection tool for CMV PCR for diagnosing congenital cytomegalovirus infection	2
Pitfalls in gastrointestinal tract haematopoietic lesions	2
Bone marrow fibrosis impact on response to azacitidine in myelodysplastic syndromes	2
Ovarian mesonephric-like adenocarcinoma: morphological diversity and histogenetic considerations of an unusual tumour	2
Using long-read RNA sequencing to decipher the role of RNA isoforms in disease	2
Precision diagnostics: integration of tissue pathology and genomics in cancer	2
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort	2